NU2058
Based on 1 Customer Validation
NU2058 (O6-(Cyclohexylmethyl)guanine) is a potent, competitive and guanine-based CDK inhibitor with IC50s of 17 μM and 26 μM for CDK2 and CDK1. NU2058 has anti-cancer activity.
For research use only. We do not sell to patients.
- Purity: 99.66%
- CAS No.: 161058-83-9
- Formula: C12H17N5O
- Molecular Weight:247.30
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Cell Cycle/DNA Damage Compound Library
HY-L004
-
Kinase Inhibitor Library
HY-L009
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
-
Nucleotide Compound Library
HY-L044
-
Anti-Breast Cancer Compound Library
HY-L074
-
Anti-Blood Cancer Compound Library
HY-L079
-
Cancer Stem Cells Compound Library
HY-L135
-
Heterocyclic Compound Library
HY-L138
-
Highly Selective Inhibitors Library
HY-L158
-
Serine/Threonine Kinase Inhibitor Library
HY-L164
-
Anti-Hematopathy Compound Library
HY-L171
-
Anti-Ovarian Cancer Compound Library
HY-L173
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Protein Kinase Compound Library
HY-L196
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
-
Posttranslational Modification Library
HY-L226
-
High-Efficiency Gene Editing Compound Library
HY-L244
Biological Activity
|
CDK1 26 μM (IC50) |
CDK2 17 μM (IC50) |
CDK2 12 μM (Ki) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
>1000 μM
Compound: 20
|
concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract.
concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract.
|
[PMID: 11063604] |
| MCF7 | GI50 |
20 μM
Compound: 25
|
Inhibition of MCF-7 human breast carcinoma cell proliferation
Inhibition of MCF-7 human breast carcinoma cell proliferation
|
[PMID: 12139449] |
| MCF7 | IC50 |
24.2 μM
Compound: 1, NU2058
|
Antiproliferative activity against human MCF7 cells after 3 days by SRB assay
Antiproliferative activity against human MCF7 cells after 3 days by SRB assay
|
[PMID: 18069093] |
NU2058 (O6-(Cyclohexylmethyl)guanine) is a competitive inhibitor of CDK2 with respect to ATP (Ki value CDK2, 12 μM) that binds in the ATP binding pocket in a different orientation from other purine-based inhibitors, including olomoucine and roscovotine. NU2058 is the lead compound in a structure-based drug discovery program to develop more potent and selective CDK inhibitors.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 161058-83-9
-
Appearance Solid
-
Molecular Weight 247.30
-
Formula C12H17N5O
-
Color White to off-white
-
SMILES
NC1=NC(OCC2CCCCC2)=C3NC=NC3=N1
-
Synonyms
O6-(Cyclohexylmethyl)guanine
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Solvent & Solubility
DMSO : ≥ 32 mg/mL (129.40 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0437 mL | 20.2184 mL | 40.4367 mL | 101.0918 mL |
| 5 mM | 0.8087 mL | 4.0437 mL | 8.0873 mL | 20.2184 mL | |
| 10 mM | 0.4044 mL | 2.0218 mL | 4.0437 mL | 10.1092 mL | |
| 15 mM | 0.2696 mL | 1.3479 mL | 2.6958 mL | 6.7395 mL | |
| 20 mM | 0.2022 mL | 1.0109 mL | 2.0218 mL | 5.0546 mL | |
| 25 mM | 0.1617 mL | 0.8087 mL | 1.6175 mL | 4.0437 mL | |
| 30 mM | 0.1348 mL | 0.6739 mL | 1.3479 mL | 3.3697 mL | |
| 40 mM | 0.1011 mL | 0.5055 mL | 1.0109 mL | 2.5273 mL | |
| 50 mM | 0.0809 mL | 0.4044 mL | 0.8087 mL | 2.0218 mL | |
| 60 mM | 0.0674 mL | 0.3370 mL | 0.6739 mL | 1.6849 mL | |
| 80 mM | 0.0505 mL | 0.2527 mL | 0.5055 mL | 1.2636 mL | |
| 100 mM | 0.0404 mL | 0.2022 mL | 0.4044 mL | 1.0109 mL |
NU2058 Related Classifications
HY-19316 Related Classifications
Powered by Bioz